Edition:
United Kingdom

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,479.20GBp
16 Jan 2019
Change (% chg)

-29.40 (-1.95%)
Prev Close
1,508.60
Open
1,506.40
Day's High
1,506.40
Day's Low
1,476.20
Volume
4,412,731
Avg. Vol
8,618,844
52-wk High
1,648.80
52-wk Low
1,235.20

Chart for

About

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare... (more)

Overall

Beta: 1.21
Market Cap(Mil.): £75,181.28
Shares Outstanding(Mil.): 4,918.63
Dividend: 19.00
Yield (%): --

Financials

  GSK.L Industry Sector
P/E (TTM): 38.75 31.12 34.38
EPS (TTM): 0.39 -- --
ROI: 7.58 15.55 14.96
ROE: 278.84 16.93 16.53

UK Stocks-Factors to watch on Jan 9

Jan 9 - Britain's FTSE 100 index is seen opening 75 points higher at 6,936 on Wednesday, according to financial bookmakers. * INTERNATIONAL CONSOLIDATED AIRLINES: Brussels has warned British Airways owner IAG that its favoured strategy to allow it to continue flying freely in and around Europe in the event of a no-deal Brexit will not work, the Financial Times reported on Tuesday. * FAROE PETROLEUM: Norwegian oil company DNO ASA said on Tuesday it raised its cash offer for Faroe Petr

09 Jan 2019

GlaxoSmithKline to look for early-stage assets - CEO

GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker's chief executive officer said on Tuesday.

08 Jan 2019

GlaxoSmithKline to look for early-stage assets: CEO

GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker's chief executive officer said on Tuesday.

08 Jan 2019

UPDATE 1-GlaxoSmithKline to look for early-stage assets - CEO

Jan 8 GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker's chief executive officer said on Tuesday.

08 Jan 2019

GlaxoSmithKline to look for early-stage assets - CEO

Jan 8 GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the British drugmaker's chief executive officer said on Tuesday.

08 Jan 2019

PRESS DIGEST - Wall Street Journal - Dec 20

Dec 20 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

20 Dec 2018

GSK pulls FTSE 100 out of three-day rut, focus on Fed

Pharmaceuticals giant GSK helped Britain's main bourse break a three-day losing streak even as all eyes were on the Fed, ahead of a key announcement that will set the course of interest-rate hikes in the world's largest economy.

19 Dec 2018

Drugmaker GSK to split after striking Pfizer consumer health deal

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video

19 Dec 2018

Drugmaker GSK to split after striking Pfizer consumer health deal

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video

19 Dec 2018

UPDATE 2-Drugmaker GSK to split after striking Pfizer consumer health deal

* GSK shares up 7 percent (Adds CEO comments, latest shares, analyst reaction, advisers)

19 Dec 2018

Earnings vs. Estimates